Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function
about
Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot studyNeuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.Association of maternal and fetal LEPR common variants with maternal glycemic traits during pregnancyCommon genetic variation in the human CTF1 locus, encoding cardiotrophin-1, determines insulin sensitivity.Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin.Association of common genetic variants in the MAP4K4 locus with prediabetic traits in humans.Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivityComparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy males.Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers.Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content.Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study.Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients.Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion.The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans.Insulin sensitivity and β-cell function in normoglycemic offspring of individuals with type 2 diabetes mellitus: Impact of line of inheritance.Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status.DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposityA novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway.Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy.Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions.Short-term glucagon stimulation test of C-peptide effect on glucose utilization in patients with type 1 diabetes mellitus.Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.Chronic noise-exposure exacerbates insulin resistance and promotes the manifestations of the type 2 diabetes in a high-fat diet mouse model.Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans.
P2860
Q28481414-2297A175-E084-4587-94EB-FC1F57C7BA7DQ30448605-3A7F6C94-33BA-4D41-ABA0-AB2B2FC58094Q33780487-B6794815-614A-4B9B-9990-52FB062A7692Q33904645-A40E8BE6-9ADF-44AA-98E9-7A0C33D8BE32Q34009469-4E44FD45-65F2-4EFE-9A46-5DE40B82FAC9Q34456436-E0E28565-51A2-476D-8412-B4FBE842049BQ34700737-0BBD87EF-71F9-4A2B-9DD8-7E7CA2DC579CQ35669476-F33A1CE0-E30F-4402-B421-43AAA623DFAAQ35866957-2D37EE52-88F9-488F-82D9-01148C163243Q35883812-14EAF925-C98D-46EC-B86A-012BE47EB8F6Q36867593-80134086-B6B7-401D-BD50-ED941D508CCCQ36999932-B87693A4-43B6-42AC-8E30-249984FCFE82Q37048197-0C88C6D4-2EFF-458F-B967-6EC4401EE5ACQ37173325-DE474FF1-0065-4582-8161-CD4183D9A32DQ40245292-949819C3-11BE-488C-AE0D-A9A144A05BDCQ40567389-D888316E-A406-4B6F-982D-29FDB3151CBCQ41055915-7F433968-F9C8-46AC-8C76-A995A2758094Q41153628-3B94044B-A6A1-4058-8CD1-C86DB896E242Q47137408-46F80656-46A0-4CD7-ADED-AC41B26C5C15Q48076623-F831D90C-8FFD-4EFD-8DE4-FFCCFA1581E9Q48604994-973FD541-47FE-4C69-B9E2-2DAD39C41792Q48713252-42A1DFE4-B94B-445A-AF27-F1F01392C78DQ49644181-6167B46B-7AE4-4DD2-AE61-7F123B74F506Q52619007-EB83DA1B-7CBA-4D30-9ABF-B2835D15351FQ54963131-85E4A77C-8C01-4D87-855A-0DD582BEB9A2
P2860
Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Evaluation of fasting state-/o ...... cally impaired β-cell function
@ast
Evaluation of fasting state-/o ...... cally impaired β-cell function
@en
Evaluation of fasting state-/o ...... cally impaired β-cell function
@nl
type
label
Evaluation of fasting state-/o ...... cally impaired β-cell function
@ast
Evaluation of fasting state-/o ...... cally impaired β-cell function
@en
Evaluation of fasting state-/o ...... cally impaired β-cell function
@nl
prefLabel
Evaluation of fasting state-/o ...... cally impaired β-cell function
@ast
Evaluation of fasting state-/o ...... cally impaired β-cell function
@en
Evaluation of fasting state-/o ...... cally impaired β-cell function
@nl
P2093
P2860
P50
P1433
P1476
Evaluation of fasting state-/o ...... cally impaired β-cell function
@en
P2093
Andreas Fritsche
Caroline Ketterer
Fausto Machicao
Konstantinos Kantartzis
Martina Guthoff
Silke A Herzberg-Schäfer
P2860
P304
P356
10.1371/JOURNAL.PONE.0014194
P407
P577
2010-12-02T00:00:00Z